Literature DB >> 28245783

Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and their Derivatives.

Xu Zhang1, Jia-Hua Cui2, Qing-Qing Meng2, Shao-Shun Li2, Wen Zhou3, Sui Xiao1.   

Abstract

Shikonin, alkannin and their derivatives, the main ingredient of Lithospermum erythrorhizon and Arnebia euchroma (Royle) Johnst native to Inner Mongolian and Northwest of China respectively, hold promising potentials for antitumor effects via multiple-target mechanisms. This review will emphasize the importance of their antitumor activity in apoptosis, necroptosis and immunogenic cell death, and expound the relationship of their antitumor activity and naphthoquinone scaffold that could generate ROS and alkylating agent. Meanwhile, the antitumor mechanisms of naturally-occurring shikonin, alkannin and their derivatives, which were divided into the direct interaction involved in alkylating agent, covalently binding the DNA and protein, as well as the indirect interaction mediated by ROS, nonspecifically influencing the mitochondria or multiple signal pathways, will be systematically summarized and discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alkannin; DNA; ROS; anti-tumor mechanisms; bioalkylation; shikonin

Mesh:

Substances:

Year:  2018        PMID: 28245783     DOI: 10.2174/1389557517666170228114809

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  14 in total

1.  Shikonin reduces hepatic fibrosis by inducing apoptosis and inhibiting autophagy via the platelet-activating factor-mitogen-activated protein kinase axis.

Authors:  Min Song; Heng Zhang; Zhitao Chen; Jing Yang; Jie Li; Sue Shao; Jing Liu
Journal:  Exp Ther Med       Date:  2020-11-10       Impact factor: 2.447

2.  Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation.

Authors:  Yan Su; Shiyou Lu; Jincun Li; Liya Deng
Journal:  Toxicol Res (Camb)       Date:  2018-06-06       Impact factor: 3.524

3.  A Discovery Strategy for Active Compounds of Chinese Medicine Based on the Prediction Model of Compound-Disease Relationship.

Authors:  Mengqi Huo; Sha Peng; Jing Li; Yanling Zhang; Yanjiang Qiao
Journal:  J Oncol       Date:  2022-07-08       Impact factor: 4.501

Review 4.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

Review 5.  Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017.

Authors:  Yanfei Liu; Mingyue Sun; Hezhi Yao; Yue Liu; Rui Gao
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-25       Impact factor: 2.629

Review 6.  PKM2, function and expression and regulation.

Authors:  Ze Zhang; Xinyue Deng; Yuanda Liu; Yahui Liu; Liankun Sun; Fangfang Chen
Journal:  Cell Biosci       Date:  2019-06-26       Impact factor: 7.133

7.  Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells.

Authors:  Qing Tang; Lihua Liu; Hongyan Zhang; Jing Xiao; Swei Sunny Hann
Journal:  Drug Des Devel Ther       Date:  2020-02-11       Impact factor: 4.162

8.  Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  J Ethnopharmacol       Date:  2021-01-21       Impact factor: 5.195

9.  Non-cytotoxic doses of shikonin inhibit lipopolysaccharide-induced TNF-α expression via activation of the AMP-activated protein kinase signaling pathway.

Authors:  Fang Zhang; Tao Pan; Xiaohui Wu; Xingchun Gao; Zhikui Li; Xinling Ren
Journal:  Exp Ther Med       Date:  2020-09-03       Impact factor: 2.447

10.  Breast Cancer Stem Cell Potency of Nickel(II)-Polypyridyl Complexes Containing Non-steroidal Anti-inflammatory Drugs.

Authors:  Catherine J Feld; Alice Johnson; Zhiyin Xiao; Kogularamanan Suntharalingam
Journal:  Chemistry       Date:  2020-09-30       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.